MoCRA Product Safety Substantiation: Building Scientific Proof for U.S. Market Compliance

0
263
Building Scientific Proof for U.S. Market Compliance
Building Scientific Proof for U.S. Market Compliance

MoCRA product safety substantiation is a central compliance obligation under the Modernization of Cosmetics Regulation Act and a key pillar of FDA oversight for cosmetic products in the United States. We support Responsible Persons and cosmetic companies in establishing scientifically robust safety documentation that meets regulatory expectations and withstands FDA scrutiny.

MoCRA significantly elevates the responsibility of the Responsible Person (RP) by requiring continuous access to safety substantiation records for every cosmetic product placed on the U.S. market. These records must demonstrate, with reasonable scientific certainty, that a product is safe for its intended use. While the legislation intentionally allows flexibility in how safety is substantiated, it sets a high evidentiary standard that must be met through credible scientific evaluation.

Scientific Basis of Safety Substantiation Under MoCRA

MoCRA defines safety substantiation as evidence derived from tests, studies, analyses, research, or other scientifically valid information that qualified experts consider sufficient to support product safety. This places the focus not on formal templates, but on scientific justification, data quality, and expert interpretation.

In practice, the cosmetics industry broadly aligns MoCRA product safety substantiation with the principles of EU Regulation 1223/2009, which has long established a structured and globally recognized approach to cosmetic safety assessment. This alignment allows companies operating internationally to leverage existing safety frameworks while adapting them to U.S. regulatory expectations.

Anticipating FDA Focus Areas and Regulatory Evolution

MoCRA also strengthens the FDA’s ability to respond to emerging safety concerns. A notable example is the upcoming official FDA method for detecting asbestos in cosmetic products containing talc, which will introduce additional analytical and documentation requirements for affected formulations.

In parallel, the FDA is actively evaluating the safety profile of perfluoroalkyl and polyfluoroalkyl substances (PFAS) used in cosmetics. As regulatory conclusions emerge, Responsible Persons may be required to reassess product formulations, update safety documentation, or implement risk mitigation measures. Maintaining adaptable and up-to-date safety substantiation is therefore essential for long-term compliance.

Core Components of Effective Safety Documentation

Robust product safety substantiation is built on a comprehensive evaluation of both ingredients and finished products. This includes toxicological assessments supported by scientific literature, analytical data, supplier documentation, and, where necessary, additional testing or studies.

Safety documentation must cover raw materials, finished product composition, and packaging interactions, ensuring a holistic evaluation of potential risks. All data must remain current and scientifically valid. Crucially, the toxicological assessment must be conducted by a qualified safety assessor with appropriate scientific training and experience in cosmetic safety evaluation.

Risk Management Through Proactive Compliance

Rather than viewing safety substantiation as a static requirement, we approach it as an ongoing compliance process. Continuous monitoring of regulatory developments, ingredient evaluations, and scientific updates allows Responsible Persons to anticipate regulatory changes and reduce the risk of enforcement actions or market disruption.

Our Role in MoCRA Safety Compliance

With more than ten years of experience in cosmetic safety documentation, we support companies through every phase of safety substantiation, from initial scientific assessment to regulatory readiness. Our services integrate seamlessly with MoCRA requirements such as facility registration, product listing, and U.S. Responsible Person support, ensuring a coherent and efficient compliance strategy.

About CE.way

We are CE.way, an international regulatory consultancy specializing in cosmetic compliance across the U.S., EU, and global markets. Our team combines regulatory expertise with scientific rigor, helping cosmetic brands translate complex requirements into practical compliance solutions.

To ensure regulatory confidence and FDA readiness, our MoCRA product safety substantiation services provide Responsible Persons with the scientific foundation required for safe and compliant U.S. market entry.